FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4221085162> ?p ?o ?g. }

• W4221085162 abstract "Abstract Background Since December 14, 2020, New York City (NYC) has started the first batch of COVID-19 vaccines. However, the shortage of vaccines is currently an inevitable problem. Therefore, optimizing the age-specific COVID-19 vaccination is an important issue that needs to be addressed as a priority. Objective Combined with the reported COVID-19 data in NYC, this study aimed to construct a mathematical model with five age groups to estimate the impact of age-specific vaccination on reducing the prevalence of COVID-19. Methods We proposed an age-structured mathematical model and estimated the unknown parameters based on the method of Markov Chain Monte Carlo (MCMC). We also calibrated our model by using three different types of reported COVID-19 data in NYC. Moreover, we evaluated the reduced cumulative number of deaths and new infections with different vaccine allocation strategies. Results Compared with the current vaccination strategy in NYC, if we gradually increased the vaccination coverage rate for only one age groups from March 1, 2021 such that the vaccination coverage rate would reach to 40% by June 1, 2021, then as of June 1, 2021, the cumulative deaths in the 75–100 age group would be reduced the most, about 72 fewer deaths per increased 100,000 vaccinated individuals, and the cumulative new infections in the 0–17 age group would be reduced the most, about 21,591 fewer new infections per increased 100,000 vaccinated individuals. If we gradually increased the vaccination coverage rate for two age groups from March 1, 2021 such that the vaccination coverage rate would reach to 40% by June 1, 2021, then as of June 1, 2021, the cumulative deaths in the 65–100 age group would be reduced the most, about 36 fewer deaths per increased 100,000 vaccinated individuals, and the cumulative new infections in the 0–44 age group would be reduced the most, about 17,515 fewer new infections per increased 100,000 vaccinated individuals. In addition, if we had an additional 100,000 doses of vaccine for 0–17 and 75–100 age groups as of June 1, 2021, then the allocation of 80% to the 0–17 age group and 20% to the 75–100 age group would reduce the maximum numbers of new infections and deaths simultaneously in NYC. Conclusions The COVID-19 burden including deaths and new infections would decrease with increasing vaccination coverage rate. Priority vaccination to the elderly and adolescents would minimize both deaths and new infections." @default.
• W4221085162 created "2022-04-03" @default.
• W4221085162 creator A5010776860 @default.
• W4221085162 creator A5046202286 @default.
• W4221085162 creator A5050861817 @default.
• W4221085162 creator A5071310326 @default.
• W4221085162 creator A5076363304 @default.
• W4221085162 creator A5083390217 @default.
• W4221085162 creator A5087071544 @default.
• W4221085162 date "2022-03-15" @default.
• W4221085162 modified "2023-10-16" @default.
• W4221085162 title "COVID-19 epidemic in New York City: development of an age group-specific mathematical model to predict the outcome of various vaccination strategies" @default.
• W4221085162 cites W1831547158 @default.
• W4221085162 cites W2151689585 @default.
• W4221085162 cites W2295803031 @default.
• W4221085162 cites W3015197879 @default.
• W4221085162 cites W3023058754 @default.
• W4221085162 cites W3043025614 @default.
• W4221085162 cites W3047996516 @default.
• W4221085162 cites W3048372007 @default.
• W4221085162 cites W3090578064 @default.
• W4221085162 cites W3095617974 @default.
• W4221085162 cites W3113666824 @default.
• W4221085162 cites W3123021790 @default.
• W4221085162 cites W3128418047 @default.
• W4221085162 cites W3129261802 @default.
• W4221085162 cites W3131501116 @default.
• W4221085162 cites W3131686432 @default.
• W4221085162 cites W3134220136 @default.
• W4221085162 cites W3137307037 @default.
• W4221085162 cites W3138763261 @default.
• W4221085162 cites W3140873963 @default.
• W4221085162 cites W3153039449 @default.
• W4221085162 cites W3155288998 @default.
• W4221085162 cites W3157719597 @default.
• W4221085162 cites W3158778663 @default.
• W4221085162 cites W3158922727 @default.
• W4221085162 cites W3160226052 @default.
• W4221085162 cites W3170598451 @default.
• W4221085162 cites W3210642859 @default.
• W4221085162 cites W3211430680 @default.
• W4221085162 cites W3212487860 @default.
• W4221085162 cites W3214683919 @default.
• W4221085162 cites W4200293390 @default.
• W4221085162 cites W4361865032 @default.
• W4221085162 doi "https://doi.org/10.1186/s12985-022-01771-9" @default.
• W4221085162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35292054" @default.
• W4221085162 hasPublicationYear "2022" @default.
• W4221085162 type Work @default.
• W4221085162 citedByCount "2" @default.
• W4221085162 countsByYear W42210851622023 @default.
• W4221085162 crossrefType "journal-article" @default.
• W4221085162 hasAuthorship W4221085162A5010776860 @default.
• W4221085162 hasAuthorship W4221085162A5046202286 @default.
• W4221085162 hasAuthorship W4221085162A5050861817 @default.
• W4221085162 hasAuthorship W4221085162A5071310326 @default.
• W4221085162 hasAuthorship W4221085162A5076363304 @default.
• W4221085162 hasAuthorship W4221085162A5083390217 @default.
• W4221085162 hasAuthorship W4221085162A5087071544 @default.
• W4221085162 hasBestOaLocation W42210851621 @default.
• W4221085162 hasConcept C126322002 @default.
• W4221085162 hasConcept C138885662 @default.
• W4221085162 hasConcept C144024400 @default.
• W4221085162 hasConcept C149923435 @default.
• W4221085162 hasConcept C194051981 @default.
• W4221085162 hasConcept C203014093 @default.
• W4221085162 hasConcept C22070199 @default.
• W4221085162 hasConcept C2778137410 @default.
• W4221085162 hasConcept C2779134260 @default.
• W4221085162 hasConcept C2986834420 @default.
• W4221085162 hasConcept C3008058167 @default.
• W4221085162 hasConcept C41895202 @default.
• W4221085162 hasConcept C524204448 @default.
• W4221085162 hasConcept C71924100 @default.
• W4221085162 hasConceptScore W4221085162C126322002 @default.
• W4221085162 hasConceptScore W4221085162C138885662 @default.
• W4221085162 hasConceptScore W4221085162C144024400 @default.
• W4221085162 hasConceptScore W4221085162C149923435 @default.
• W4221085162 hasConceptScore W4221085162C194051981 @default.
• W4221085162 hasConceptScore W4221085162C203014093 @default.
• W4221085162 hasConceptScore W4221085162C22070199 @default.
• W4221085162 hasConceptScore W4221085162C2778137410 @default.
• W4221085162 hasConceptScore W4221085162C2779134260 @default.
• W4221085162 hasConceptScore W4221085162C2986834420 @default.
• W4221085162 hasConceptScore W4221085162C3008058167 @default.
• W4221085162 hasConceptScore W4221085162C41895202 @default.
• W4221085162 hasConceptScore W4221085162C524204448 @default.
• W4221085162 hasConceptScore W4221085162C71924100 @default.
• W4221085162 hasFunder F4320321001 @default.
• W4221085162 hasFunder F4320335787 @default.
• W4221085162 hasIssue "1" @default.
• W4221085162 hasLocation W42210851621 @default.
• W4221085162 hasLocation W42210851622 @default.
• W4221085162 hasLocation W42210851623 @default.
• W4221085162 hasLocation W42210851624 @default.
• W4221085162 hasOpenAccess W4221085162 @default.
• W4221085162 hasPrimaryLocation W42210851621 @default.
• W4221085162 hasRelatedWork W2012600241 @default.
• W4221085162 hasRelatedWork W2509147714 @default.
• W4221085162 hasRelatedWork W2579473328 @default.

• next